Quickly assess whether a new idea is worth protecting, and how strong a published patent really is. Patenter checks both against the prior art, with every finding traced to its evidence.
Explore an unpublished invention: its inventive features and its novelty and non-obviousness against the prior art.
Assess a published application or granted patent: novelty, non-obviousness, freedom to operate and the key risks.
Disclosures and publications grow with your research budget. The staff and counsel who assess them do not. So potentially protectable inventions go unscreened. Yet federal funders still expect you to identify them. Patenter gives every disclosure and paper a baseline screen, so expert time goes to the inventions most worth protecting.
An issued patent is not the same as a strong one. Outside opinions on every asset in a deal are slow and expensive, so most diligence checks a few patents, or takes the portfolio on trust. Patenter identifies the risks in every patent and application in the deal, on your timeline, at a fixed price per asset.
Find out whether your idea is dead on arrival before you spend on a filing, and give investors an independent view of the patents you already have.
Patenter captures the invention, organizes the materials and runs the prior-art analysis, so your time goes to judgment and drafting. It speeds up the preparatory work. The filing is still yours.
For an invention that isn't published yet. Start from scratch, or bring notes, a draft, a TTO disclosure form or a preprint.
For a published application or granted patent. You'll need the publication or patent number to start.
Patenter partners with consortia and federal innovation programs to accelerate the path from discovery to deployment.
MTEC is a DoD-focused nonprofit that funds medical technology development.
A military- and medical-connected community empowering MedTech, Biotech, and Pharma companies with access to Operational and Clinical subject matter experts, non-dilutive DoD/Federal R&D funding, and commercialization resources.
Start from an idea, a draft or a preprint, or enter a publication number. You get the same evidence-backed output we deliver to tech transfer offices, investors and patent counsel.
